- Home
- PRLD vs FATBB Comparison
PRLD vs FATBB Comparison
Compare PRLD & FATBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- FATBB
- Stock Information
- Founded
- PRLD 2016
- FATBB 2017
- Country
- PRLD United States
- FATBB United States
- Employees
- PRLD N/A
- FATBB N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- FATBB Restaurants
- Sector
- PRLD Health Care
- FATBB Consumer Discretionary
- Exchange
- PRLD Nasdaq
- FATBB Nasdaq
- Market Cap
- PRLD 73.7M
- FATBB 71.5M
- IPO Year
- PRLD 2020
- FATBB N/A
- Fundamental
- Price
- PRLD $0.87
- FATBB $3.50
- Analyst Decision
- PRLD Strong Buy
- FATBB
- Analyst Count
- PRLD 2
- FATBB 0
- Target Price
- PRLD $4.50
- FATBB N/A
- AVG Volume (30 Days)
- PRLD 200.4K
- FATBB 12.8K
- Earning Date
- PRLD 03-04-2025
- FATBB 01-01-0001
- Dividend Yield
- PRLD N/A
- FATBB 16.00%
- EPS Growth
- PRLD N/A
- FATBB N/A
- EPS
- PRLD N/A
- FATBB N/A
- Revenue
- PRLD $3,000,000.00
- FATBB $606,008,000.00
- Revenue This Year
- PRLD N/A
- FATBB $27.15
- Revenue Next Year
- PRLD N/A
- FATBB $10.38
- P/E Ratio
- PRLD N/A
- FATBB N/A
- Revenue Growth
- PRLD N/A
- FATBB 42.38
- 52 Week Low
- PRLD $0.80
- FATBB $2.62
- 52 Week High
- PRLD $6.80
- FATBB $5.18
- Technical
- Relative Strength Index (RSI)
- PRLD 37.59
- FATBB 43.80
- Support Level
- PRLD $0.87
- FATBB $3.50
- Resistance Level
- PRLD $1.01
- FATBB $3.80
- Average True Range (ATR)
- PRLD 0.08
- FATBB 0.31
- MACD
- PRLD -0.02
- FATBB -0.12
- Stochastic Oscillator
- PRLD 0.90
- FATBB 0.00
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About FATBB FAT Brands Inc. Class B
FAT Brands Inc is a multi-brand restaurant franchising company. It develops, markets, acquires and manages quick service, fast casual, casual dining, and polished casual dining restaurant concepts around the world. The company operates as a franchisor of restaurants, where the company generally does not own or operate the restaurant locations but rather generates revenue by charging franchisees an initial franchise fee as well as ongoing royalties. For some of the company's brands, it also directly owns and operates restaurant locations. Its brands include Round Table Pizza, Fatburger, Johnny Rockets, Twin Peaks, and Elevation Burger among others. Geographically, the majority of the revenue for the company is generated from the United States and the rest from other countries.